Annual Current Liabilities
$22.64 M
-$3.92 M-14.76%
31 December 2023
Summary:
Silence Therapeutics annual total current liabilities is currently $22.64 million, with the most recent change of -$3.92 million (-14.76%) on 31 December 2023. During the last 3 years, it has fallen by -$12.22 million (-35.06%). SLN annual current liabilities is now -35.06% below its all-time high of $34.85 million, reached on 31 December 2020.SLN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$22.63 M
-$59.90 K-0.26%
01 September 2024
Summary:
Silence Therapeutics quarterly total current liabilities is currently $22.63 million, with the most recent change of -$59.90 thousand (-0.26%) on 01 September 2024. Over the past year, it has increased by +$650.60 thousand (+2.96%). SLN quarterly current liabilities is now -35.06% below its all-time high of $34.85 million, reached on 31 December 2020.SLN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.8% | +3.0% |
| 3 y3 years | -35.1% | -8.4% |
| 5 y5 years | +365.8% | +78.8% |
SLN Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.1% | +10.6% | -21.9% | +26.5% |
| 5 y | 5 years | -35.1% | +365.8% | -35.1% | +99.2% |
| alltime | all time | -35.1% | +4748.1% | -35.1% | +3539.9% |
Silence Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.63 M(-0.3%) |
| June 2024 | - | $22.69 M(+26.8%) |
| Mar 2024 | - | $17.90 M(-20.9%) |
| Dec 2023 | $22.64 M(-14.8%) | $22.64 M(+3.0%) |
| Sept 2023 | - | $21.98 M(-10.9%) |
| June 2023 | - | $24.67 M(+12.1%) |
| Mar 2023 | - | $22.00 M(-17.2%) |
| Dec 2022 | $26.56 M(+29.7%) | $26.56 M(-8.3%) |
| Sept 2022 | - | $28.96 M(+22.1%) |
| June 2022 | - | $23.72 M(+14.8%) |
| Mar 2022 | - | $20.66 M(+0.9%) |
| Dec 2021 | $20.47 M(-41.3%) | $20.47 M(-17.1%) |
| Sept 2021 | - | $24.70 M(+20.9%) |
| June 2021 | - | $20.43 M(-41.4%) |
| Dec 2020 | $34.85 M(+175.4%) | $34.85 M(+206.7%) |
| June 2020 | - | $11.36 M(-10.2%) |
| Dec 2019 | $12.66 M(+160.4%) | - |
| Dec 2019 | - | $12.66 M(+249.3%) |
| June 2019 | - | $3.62 M(-25.4%) |
| Dec 2018 | $4.86 M(+35.3%) | - |
| Dec 2018 | - | $4.86 M(+3.2%) |
| June 2018 | - | $4.71 M(+31.2%) |
| Dec 2017 | $3.59 M(+81.5%) | - |
| Dec 2017 | - | $3.59 M(-0.3%) |
| June 2017 | - | $3.60 M(+82.1%) |
| Dec 2016 | $1.98 M(+19.4%) | - |
| Dec 2016 | - | $1.98 M(-3.3%) |
| June 2016 | - | $2.05 M(+23.5%) |
| Dec 2015 | $1.66 M(-47.1%) | - |
| Dec 2015 | - | $1.66 M(+13.7%) |
| June 2015 | - | $1.46 M(-53.5%) |
| Dec 2014 | $3.13 M(+10.2%) | - |
| Dec 2014 | - | $3.13 M(+20.5%) |
| June 2014 | - | $2.60 M(-8.5%) |
| Dec 2013 | $2.84 M(+83.4%) | - |
| Dec 2013 | - | $2.84 M(+100.2%) |
| June 2013 | - | $1.42 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $1.55 M(-20.2%) | - |
| Dec 2012 | - | $1.55 M(+1.8%) |
| June 2012 | - | $1.52 M(-21.6%) |
| Dec 2011 | $1.94 M(-25.4%) | - |
| Dec 2011 | - | $1.94 M(-41.7%) |
| June 2011 | - | $3.33 M(+28.0%) |
| Dec 2010 | $2.60 M(-23.5%) | - |
| Dec 2010 | - | $2.60 M(-36.7%) |
| June 2010 | - | $4.11 M(+20.8%) |
| Dec 2009 | $3.40 M(+148.3%) | - |
| Dec 2009 | - | $3.40 M(+149.5%) |
| June 2009 | - | $1.36 M(-0.5%) |
| Dec 2008 | $1.37 M(-61.7%) | - |
| Dec 2008 | - | $1.37 M(-12.6%) |
| June 2008 | - | $1.57 M(-56.2%) |
| Dec 2007 | $3.58 M(+75.0%) | - |
| Dec 2007 | - | $3.58 M(-7.6%) |
| June 2007 | - | $3.87 M(+89.4%) |
| Dec 2006 | $2.04 M(-11.5%) | - |
| Dec 2006 | - | $2.04 M(+29.7%) |
| June 2006 | - | $1.58 M(-31.7%) |
| Dec 2005 | $2.31 M(+271.5%) | - |
| Dec 2005 | - | $2.31 M(+82.8%) |
| June 2005 | - | $1.26 M(+103.2%) |
| Dec 2004 | $621.80 K(-73.4%) | - |
| Dec 2004 | - | $621.80 K(-58.3%) |
| June 2004 | - | $1.49 M(-36.2%) |
| Dec 2003 | $2.34 M(+40.9%) | - |
| Dec 2003 | - | $2.34 M(+23.5%) |
| June 2003 | - | $1.89 M |
| Dec 2002 | $1.66 M(+57.8%) | - |
| Dec 2001 | $1.05 M(-26.9%) | - |
| Dec 2000 | $1.44 M(-44.5%) | - |
| Dec 1999 | $2.59 M(+159.7%) | - |
| Dec 1998 | $997.30 K(-5.9%) | - |
| Dec 1997 | $1.06 M(+49.6%) | - |
| Dec 1996 | $708.70 K(+51.8%) | - |
| Dec 1995 | $466.90 K | - |
FAQ
- What is Silence Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Silence Therapeutics?
- What is Silence Therapeutics annual current liabilities year-on-year change?
- What is Silence Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Silence Therapeutics?
- What is Silence Therapeutics quarterly current liabilities year-on-year change?
What is Silence Therapeutics annual total current liabilities?
The current annual current liabilities of SLN is $22.64 M
What is the all time high annual current liabilities for Silence Therapeutics?
Silence Therapeutics all-time high annual total current liabilities is $34.85 M
What is Silence Therapeutics annual current liabilities year-on-year change?
Over the past year, SLN annual total current liabilities has changed by -$3.92 M (-14.76%)
What is Silence Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SLN is $22.63 M
What is the all time high quarterly current liabilities for Silence Therapeutics?
Silence Therapeutics all-time high quarterly total current liabilities is $34.85 M
What is Silence Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SLN quarterly total current liabilities has changed by +$650.60 K (+2.96%)